Soleno Therapeutics Inc

Ownership Transactions Reported by 19 Insiders

Symbol
SLNO on Nasdaq
Industry
Electromedical & Electrotherapeutic Apparatus
Location
100 Marine Parkway, Suite 400, Redwood City, CA

Insiders trading volume in the past year

Soleno Therapeutics Inc executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Abingworth LLP 10%+ Owner $658M Dec 21, 2018
Vivo Opportunity, LLC 10%+ Owner $297M -$101M -25.4% Aug 27, 2024
Perceptive Advisors Llc 10%+ Owner $112M Sep 26, 2023
Carlyle Group Inc. 10%+ Owner $55.9M Sep 28, 2023
Anish Bhatnagar CHIEF EXECUTIVE OFFICER, Director $36.2M -$19.6M -35.2% Oct 1, 2024
James Mackaness Chief Financial Officer $5.99M -$3.76M -38.6% Oct 1, 2024
Patricia C. Hirano Officer title: Senior Vice President, Regulatory Affairs $5.47M -$1.94M -26.1% Oct 1, 2024
Kristen Yen Officer title: Senior Vice President, Clinical Operations $4.09M -$3.1M -43.1% Oct 1, 2024
Meredith Manning Chief Commercial Officer $1.67M Jul 17, 2024
Michael F. Huang Sr. VP of Clinical Development $1.46M Jul 17, 2024
Jack Schuler 10%+ Owner $1.34M Dec 9, 2022
Ernest Mario Director $967K Jun 6, 2024
Dawn Carter Bir Director $597K Aug 15, 2024
William G. Harris Director $69.3K Jun 6, 2024
Birgitte Volck Director $61K Jun 6, 2024
Matthew Pauls Director $29.3K Jun 6, 2024
Andrew Sinclair Director $29.3K Jun 6, 2024
Gwen A. Melincoff Director May 25, 2023
Raymond W. Urbanski Chief Development Officer Aug 13, 2024

Recent Insider Transactions by Companies or Individuals for Soleno Therapeutics Inc

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.